ShervinTabriziMD
Radiation Oncology • Boston, MAOcular Radiation Oncology
Attending Physician, Radiation Oncology
Dr. Tabrizi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Blossom St
Boston, MA 02114Phone+1 617-724-4100
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2018 - 2022- Brigham and Womens HospitalInternship, Preliminary Year, 2017 - 2018
Harvard Medical SchoolClass of 2017
Certifications & Licensure
MA State Medical License 2017 - 2026- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever.Dylan Kotliar, Siddharth Raju, Shervin Tabrizi, Ikponmwosa Odia, Augustine Goba
Nature Microbiology. 2024-03-01 - 29 citationsPriming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies.Carmen Martin-Alonso, Shervin Tabrizi, Kan Xiong, Timothy Blewett, Sainetra Sridhar
Science. 2024-01-19 - 20 citationsBRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.Priscilla K Brastianos, Erin Twohy, Susan Geyer, Elizabeth R Gerstner, Timothy J Kaufmann
The New England Journal of Medicine. 2023-07-13
Press Mentions
Injectable Agents Could Improve Liquid Biopsy for Cancer Detection and MonitoringJanuary 20th, 2024- Research Spotlight: A Two-Part Priming Strategy to Increase the Sensitivity of Liquid BiopsiesFebruary 1st, 2024
- Researchers Uncover Genetic Factors for Severe Lassa FeverFebruary 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
